Towada Products · New Delhi, India · Last updated:
Regorafenib is an oral multikinase inhibitor used for metastatic colorectal cancer, gastrointestinal stromal tumours and liver cancer. Towada Products exports it from New Delhi, India, supplying Regonat in the 40mg strength to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. Pricing is on enquiry.
Regorafenib is an oral multikinase inhibitor, structurally related to sorafenib. It blocks kinases involved in tumour blood-vessel formation (VEGFR 1 to 3, TIE2), in the tumour environment (PDGFR, FGFR) and in tumour growth (KIT, RET, RAF).
It is approved for metastatic colorectal cancer previously treated with, or not suitable for, standard therapies such as fluoropyrimidine, oxaliplatin and irinotecan chemotherapy and anti-VEGF and anti-EGFR treatment; for gastrointestinal stromal tumours that have progressed on or are intolerant to imatinib and sunitinib; and for hepatocellular carcinoma previously treated with sorafenib. The originator brand is Stivarga.
Liver function is monitored closely, and hand-foot skin reaction is a common side effect. Sorafenib, sunitinib, imatinib and trifluridine with tipiracil are also in our catalog. Our catalog lists the 40mg tablet. The tablets are kept at room temperature in their original bottle with the desiccant, and opened bottles have a limited in-use shelf life printed on the label.
Regorafenib is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor. This page describes the medicine for trade buyers; it is not medical advice.
Every regorafenib product page on this site. "Listed for" is the use given in our catalog. Availability is confirmed when you enquire.
| Product | Composition | Listed for |
|---|---|---|
| Regonat 40mg | Regorafenib (40mg) | Cancer of colon and rectum |
Export markets we serve: Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. See our export markets →
Tell us which documents your regulator or customs broker needs and we will confirm what applies to the product you are ordering.
Regorafenib is an oral multikinase inhibitor used for metastatic colorectal cancer, gastrointestinal stromal tumours and liver cancer. It is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor.
Our catalog has 1 regorafenib product page in the 40mg strength, from 1 brand: Regonat. The table on this page links to each product page; availability is confirmed when you enquire.
We ship from New Delhi by international courier or air cargo to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa, and have country pages for the Philippines, Russia, Kazakhstan, Uzbekistan, Iraq, Saudi Arabia and Brazil. Whether regorafenib can be imported, and by whom, is decided by the destination country's medicines regulator, so tell us the country and we will confirm what is possible. Every country we cover is listed on our export markets page.
Each shipment travels with a commercial invoice, a packing list and a courier or air waybill. We provide a Certificate of Analysis (CoA) for the batch and, where it is available for the product and the destination country requires it, a Certificate of Pharmaceutical Product (CoPP). A certificate of origin can be arranged on request.
Use the enquiry form on this page, WhatsApp +91 99995 62955 or email H.S.Gandhi@towadaproducts.in. Tell us the brand, strength, quantity and destination country, and we will reply with availability and a formal quotation.
This page is general information for trade buyers. It is not medical advice. Import rules differ by country and change over time; confirm the current requirements with your national medicines regulator before ordering.
Tell us the brand, strength, quantity and destination country. Pricing is confirmed in a formal quote. Prefer WhatsApp? Message +91 99995 62955.
Plain answers to the questions importers ask before ordering medicines from India.
